| Typicality: | 0.444 |
| Saliency: | 0.454 |
| for the development of antiinflammatory therapies | 5 | purpose |
| for people | 5 | transitive-object |
| for the mechanism of eg5 | 4 | other |
| observation → have → important implications | 36 |
| observation → have → the advantage | 3 |
| observation → be → important contribution | 3 |
| negative | neutral | positive |
| 0.055 | 0.666 | 0.279 |
| Raw frequency | 42 |
| Normalized frequency | 0.454 |
| Modifier score | 0.500 |
| Perplexity | 29.590 |